Cargando…
Natural Product Ginsenoside 25-OCH(3)-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2
Although ginseng and related herbs have a long history of utility for various health benefits, their application in cancer therapy and underlying mechanisms of action are not fully understood. Our recent work has shown that 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol (25-OCH(3)-PPD), a newly ident...
Autores principales: | Wang, Wei, Zhang, Xu, Qin, Jiang-Jiang, Voruganti, Sukesh, Nag, Subhasree Ashok, Wang, Ming-Hai, Wang, Hui, Zhang, Ruiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402429/ https://www.ncbi.nlm.nih.gov/pubmed/22911819 http://dx.doi.org/10.1371/journal.pone.0041586 |
Ejemplares similares
-
Oral nano-delivery of anticancer ginsenoside 25-OCH(3)-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
por: Voruganti, Sukesh, et al.
Publicado: (2015) -
Genotoxicity and subchronic toxicological study of a novel ginsenoside derivative 25-OCH(3)-PPD in beagle dogs
por: Li, Wei, et al.
Publicado: (2019) -
Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action
por: Nag, Subhasree Ashok, et al.
Publicado: (2012) -
Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation
por: Qin, Jiang-Jiang, et al.
Publicado: (2014) -
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
por: Wang, Wei, et al.
Publicado: (2014)